Winfried F. Pickl at Medical University of Vienna Center for Pathophysiology Infectiology and Immunology Institute of Imm - Research Interests, Publications & Academic Profile

Winfried F. Pickl

University Name

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Nigerian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

90%

Virology

80%

Sars-cov-2

50%

Antibodies

40%

Allergy

20%

Immunomodulation

20%

Antibody Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Combined assessment of S‐ and N‐specific <scp>IL</scp>‐2 and <scp>IL</scp>‐13 secretion and <scp>CD69</scp> neo‐expression for discrimination of post–infection and post‐vaccination cellular <scp>SARS‐CoV</scp>‐2‐specific immune response

Article Link

Year:

2022

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

Article Link

Year:

2022

Art v 1 IgE epitopes of patients and humanized mice are conformational.

Article Link

Year:

2022

Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants.

Article Link

Year:

2022

Characterization of the antibody response to SARS-CoV-2 in a mildly affected pediatric population.

Article Link

Year:

2022

Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma.

Article Link

Year:

2022

Omicron: A SARS-CoV-2 variant of real concern.

Article Link

Year:

2022

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1

Article Link

Year:

2021

Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe : Ein Positionspapier der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und des Ärzteverbands Deutscher Allergologen (AeDA).

Article Link

Year:

2021

Value of Autoantibody Expression During Long-Term Follow-Up in Paediatric ALL Patients After Allogeneic Haematopoietic Stem Cell Transplantation.

Article Link

Year:

2021

Collaborators4

Alexander R Moschen

Professor of Medicine

Johannes Kepler University Linz

AUSTRIA

Ursula Wiedermann

Medical University of Vienna

AUSTRIA

Huey-Jy Huang

Medical University of Vienna

AUSTRIA

Rudolf Valenta

Professor for Allergology

Medical University of Vienna

AUSTRIA

How do Nigerian students reach out?

Meet Kite AI